Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.
about
Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal diseaseEffects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney diseaseLevel of inflammatory factors in chronic hemodialysis patients with and without cardiovascular disease.The deleterious effects of arteriovenous fistula-creation on the cardiovascular system: a longitudinal magnetic resonance imaging study.Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients.Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.The uremic toxin indoxyl sulphate enhances macrophage response to LPS.The link between bone and coronary calcifications in CKD-5 patients on haemodialysisOxidative stress and its association with cardiovascular disease in chronic renal failure patientsChronic Inflammation and Coronary Atherosclerosis in Patients with End-Stage Renal DiseaseWhy do dialysis patients develop a heart of stone and bone of china?Cardiovascular risk in chronic renal disease and transplantation prevention and management.Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients.Uremic pruritus: a review.Cholesterol Metabolism in CKDHypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients.Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammationChronic kidney disease (CKD) in the elderly -- a geriatrician's perspective.Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients.Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysisMatrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C-1562T Gene Polymorphism and Vitamin D Levels.Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillationMonocyte subpopulations and cardiovascular risk in chronic kidney disease.The Impact of Arteriovenous Fistulae for Hemodialysis on the Cardiovascular System.Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis.Vascular calcification and cardiovascular function in chronic kidney disease.Apelin and cardiac function in hemodialyzed patients: possible relations?Circulating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosclerosis in end-stage renal disease patients: a case control study.Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation.Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients.Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.Novel inflammatory marker in dialysis patients: YKL-40.Proportions of Proinflammatory Monocytes Are Important Predictors of Mortality Risk in Hemodialysis Patients.Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.The effect of biocompatible peritoneal dialysis solutions on neutrophil to lymphocyte ratio.
P2860
Q28730306-BD0AA1B5-17FC-4A7C-B31C-F323B49F4F39Q30658399-B532D87A-BC4C-4765-A166-ABF89010FFBDQ33660722-EB9257F1-E466-4AFD-A563-1399776E81B5Q34230374-D110657C-4359-48BA-ACBD-FB827FF764FAQ34453236-FC6A8E92-F42D-4CF3-9820-5E88D567FA68Q34747124-B68CBA14-F9D0-44DE-8B17-40B804F2E839Q34808918-6D711809-343E-4D34-8293-54F8E0219314Q34972079-DC6298B0-85B7-42FE-B96E-C06728E1A99BQ35010395-2F9EC4AD-B7E1-4231-BA36-6A0B0C87BD45Q35025415-1B25E3D3-68C5-4F9E-B91C-95D98FADEE63Q35030157-031FF647-134E-4BEA-A6D2-ED9CB65D23B1Q36036008-CE9C3C17-F7CC-40C1-AF63-550778894C1CQ36089002-1FCE7F39-99C9-4860-BBF7-175B9A2CAE7DQ36161264-2E56FF29-FD0E-4D72-9284-CEDB1625576CQ36207088-72E0FF4E-CDDC-462D-A15C-B4AE3805CA99Q36271104-68D49FA9-66A0-4B9E-A6A5-08BB8650B1D0Q36315574-9B7B5065-D734-4881-A9D4-99D4541EDB94Q36460761-9A1E58C7-FD2D-4546-BA6C-AF18289BEF09Q36665257-E07E8246-FE6D-4C4D-82B3-0A22C5A2EEBBQ36911521-0BCBC3F7-4226-4357-92A5-A39AA337163FQ37078140-3B57C2A6-40D6-4228-AACB-A30061A69E97Q37150884-4CAA6E84-6894-40A9-A181-3B9672774047Q37366411-E3DE6CF5-252F-43AA-9AB6-5F0386488C93Q37567574-CF1AE7AA-091E-4832-A82D-A3A212A67866Q37608070-7AE99396-9451-4C23-819E-AA2CDB1C4E0BQ37992796-4F27C17D-04A1-4904-B7D0-18A9F1BF59DBQ38693240-D1291F2A-FB82-4862-B90B-0FBB587A32F8Q38973363-006EBE61-9DB3-42A3-A157-D6B0BC4E6CF2Q39735035-F1D04D83-146A-4C8D-9F90-372EB52616B2Q40341428-D8E9A550-F9DD-46A3-953E-EC4A9AC83571Q43105925-98755233-693C-4F7E-9C68-70797A0136E5Q43230114-E6C10E64-D61F-46A1-BC7C-A9CC626265CBQ43552833-85CE3AFF-C91D-4DF3-BA5E-C3E7A9D28A64Q44805645-14E24C12-09F8-4321-8DF5-502BA5A5235EQ44997783-7B1304E3-539A-4D2A-AAF5-4E9ED807BFDEQ45030154-A12BFD9F-79BE-49E1-B2B4-7DF1E229DC63Q46103273-F6DB600E-D850-4D5A-AF66-3009CB72717CQ47098170-5D7CB239-C6AE-4E68-B413-E6D86D5A6244Q51032319-024DA88A-B1EF-422E-92D2-6F27B2D59C28Q53035844-9895C019-FB72-4220-859C-918E209C7A61
P2860
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.
@ast
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.
@en
type
label
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.
@ast
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.
@en
prefLabel
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.
@ast
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.
@en
P50
P1476
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem
@en
P2093
Roberto Pecoits-Filho
P304
P356
10.1097/01.ASN.0000069165.79509.42
P577
2003-07-01T00:00:00Z